Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1996-06-27
1998-07-07
Shah, Mukund J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514428, 548556, 548567, 548568, A61K 3140
Patent
active
057769729
ABSTRACT:
Pharmaceutical preparations which are suitable for the treatment of inflammatory bowel disorders and contain at least one compound of the formula I ##STR1## in which R.sup.1 is Ar, cycloalkyl having 3-7 C atoms or cycloalkylalkyl having 4-8 C atoms,
REFERENCES:
patent: 4663343 (1987-05-01), Horwell et al.
patent: 5232266 (1993-08-01), Gottschlich et al.
patent: 5232978 (1993-08-01), Gottschlich et al.
patent: 5532266 (1996-07-01), Gottschlich et al.
R. Gottschlich, K.A. Ackermann, A. Barber, G.D. Bartoszyk, H.E. Greiner Bioorganic & Medicinal Chemistry, vol. 4, No. 5, pp. 677-682, 1994.
Issselbacker et al. "Harrison's Principles of internal medicine" vol. 2, Thirteenth edition, 1403-1417, 1994.
Roger et al, Can. J. Vet. Res. vol. 58 (3), 163-166, 1994.
Upton et al. European Journal of Pharmacology, 78 (4), 412-429, 1982.
Ramabadran K. European Journal of Pharmacology, 98 (3-4), 425-427, 1984.
Bhargava et al. Brain Research, 625 (1), 120-124, 1993.
Barber et al., "A pharmacological provile of the novel, peripherally-selective . . . ", Br. J. Pharmacol. (1994), 113, 1317-1327.
Gottschlich et al., "K-Opioid Activity of the Four Stereoisomers . . . ", Chriality 6: 685-689 (1994).
Gottschlich et al., "The peripherally acting K-opiate agonist EMD . . . ", Drugs Exptl. Clin. Res., XX(5), 171-174, (1995).
Barber Andrew
Bartoszyk Gerd
Gottschlich Rudolf
Seyfried Christoph
Kifle Bruck
Merck Patent Gesellschaft mit beschrankter Haftung
Shah Mukund J.
LandOfFree
Kappa-opiate agonists for inflammatory bowel disorders does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Kappa-opiate agonists for inflammatory bowel disorders, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Kappa-opiate agonists for inflammatory bowel disorders will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1206453